Literature DB >> 18353965

Infectivity studies of influenza virus hemagglutinin receptor binding site mutants in mice.

Jeffrey Meisner1, Kristy J Szretter, Konrad C Bradley, William A Langley, Zhu-Nan Li, Byeong-Jae Lee, Sudha Thoennes, Javier Martin, John J Skehel, Rupert J Russell, Jacqueline M Katz, David A Steinhauer.   

Abstract

The replicative properties of influenza virus hemagglutinin (HA) mutants with altered receptor binding characteristics were analyzed following intranasal inoculation of mice. Among the mutants examined was a virus containing a Y98F substitution at a conserved position in the receptor binding site that leads to a 20-fold reduction in binding. This mutant can replicate as well as wild-type (WT) virus in MDCK cells and in embryonated chicken eggs but is highly attenuated in mice, exhibiting titers in lungs more than 1,000-fold lower than those of the WT. The capacity of the Y98F mutant to induce antibody responses and the structural locations of HA reversion mutations are examined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353965      PMCID: PMC2346734          DOI: 10.1128/JVI.01958-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses.

Authors:  A S Gambaryan; J S Robertson; M N Matrosovich
Journal:  Virology       Date:  1999-06-05       Impact factor: 3.616

2.  Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site.

Authors:  M N Matrosovich; A S Gambaryan; S Teneberg; V E Piskarev; S S Yamnikova; D K Lvov; J S Robertson; K A Karlsson
Journal:  Virology       Date:  1997-06-23       Impact factor: 3.616

3.  Studies of the binding properties of influenza hemagglutinin receptor-site mutants.

Authors:  J Martín; S A Wharton; Y P Lin; D K Takemoto; J J Skehel; D C Wiley; D A Steinhauer
Journal:  Virology       Date:  1998-02-01       Impact factor: 3.616

Review 4.  Virulence of influenza A virus for mouse lung.

Authors:  A C Ward
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

5.  Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species.

Authors:  T Ito; Y Suzuki; L Mitnaul; A Vines; H Kida; Y Kawaoka
Journal:  Virology       Date:  1997-01-20       Impact factor: 3.616

6.  Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection.

Authors:  T Ito; Y Suzuki; A Takada; A Kawamoto; K Otsuki; H Masuda; M Yamada; T Suzuki; H Kida; Y Kawaoka
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction.

Authors:  A Vines; K Wells; M Matrosovich; M R Castrucci; T Ito; Y Kawaoka
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

8.  Changes in H3 influenza A virus receptor specificity during replication in humans.

Authors:  K Ryan-Poirier; Y Suzuki; W J Bean; D Kobasa; A Takada; T Ito; Y Kawaoka
Journal:  Virus Res       Date:  1998-08       Impact factor: 3.303

9.  The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.

Authors:  M Matrosovich; N Zhou; Y Kawaoka; R Webster
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host.

Authors:  M Matrosovich; P Gao; Y Kawaoka
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more
  12 in total

1.  Mutation tryptophan to leucine at position 222 of haemagglutinin could facilitate H3N2 influenza A virus infection in dogs.

Authors:  Guohua Yang; Shoujun Li; Sherry Blackmon; Jianqiang Ye; Konrad C Bradley; Jim Cooley; Dave Smith; Larry Hanson; Carol Cardona; David A Steinhauer; Richard Webby; Ming Liao; Xiu-Feng Wan
Journal:  J Gen Virol       Date:  2013-09-01       Impact factor: 3.891

2.  The roles of hemagglutinin Phe-95 in receptor binding and pathogenicity of influenza B virus.

Authors:  Fengyun Ni; Innocent Nnadi Mbawuike; Elena Kondrashkina; Qinghua Wang
Journal:  Virology       Date:  2013-12-22       Impact factor: 3.616

3.  Analysis of influenza virus hemagglutinin receptor binding mutants with limited receptor recognition properties and conditional replication characteristics.

Authors:  Konrad C Bradley; Summer E Galloway; Yi Lasanajak; Xuezheng Song; Jamie Heimburg-Molinaro; Hai Yu; Xi Chen; Ganesh R Talekar; David F Smith; Richard D Cummings; David A Steinhauer
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

Review 4.  Investigating virus-glycan interactions using glycan microarrays.

Authors:  David F Smith; Richard D Cummings
Journal:  Curr Opin Virol       Date:  2014-07-01       Impact factor: 7.090

5.  Deliberate reduction of hemagglutinin and neuraminidase expression of influenza virus leads to an ultraprotective live vaccine in mice.

Authors:  Chen Yang; Steven Skiena; Bruce Futcher; Steffen Mueller; Eckard Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

6.  Sialic acid recognition is a key determinant of influenza A virus tropism in murine trachea epithelial cell cultures.

Authors:  Andrew Pekosz; Celeste Newby; Pulkit S Bose; Andrew Lutz
Journal:  Virology       Date:  2009-02-04       Impact factor: 3.616

7.  Recombinant influenza H9N2 virus with a substitution of H3 hemagglutinin transmembrane domain showed enhanced immunogenicity in mice and chicken.

Authors:  Yun Zhang; Ying Wei; Kang Liu; Mengjiao Huang; Ran Li; Yang Wang; Qiliang Liu; Jing Zheng; Chunyi Xue; Yongchang Cao
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

8.  Pathogenicity and transmission of a swine influenza A(H6N6) virus.

Authors:  Hailiang Sun; Bryan S Kaplan; Minhui Guan; Guihong Zhang; Jianqiang Ye; Li-Ping Long; Sherry Blackmon; Chun-Kai Yang; Meng-Jung Chiang; Hang Xie; Nan Zhao; Jim Cooley; David F Smith; Ming Liao; Carol Cardona; Lei Li; George Peng Wang; Richard Webby; Xiu-Feng Wan
Journal:  Emerg Microbes Infect       Date:  2017-04-12       Impact factor: 7.163

9.  A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine.

Authors:  Nicholas C Wu; Seth J Zost; Andrew J Thompson; David Oyen; Corwin M Nycholat; Ryan McBride; James C Paulson; Scott E Hensley; Ian A Wilson
Journal:  PLoS Pathog       Date:  2017-10-23       Impact factor: 6.823

10.  Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding.

Authors:  Lauren E Gentles; Hongquan Wan; Maryna C Eichelberger; Jesse D Bloom
Journal:  Viruses       Date:  2020-05-30       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.